Dr. Jared D. Sturgeon, MD

Dr. Sturgeon practices at Texas Oncology PA in Irving, Texas.

Dr. Sturgeon's NPI, 1720230063, was assigned on October 17, 2008. Dr. Sturgeon graduated from University Of Minnesota Medical School in 2008. Dr. Sturgeon holds Texas license N9966.

Dr. Sturgeon's primary practice is Texas Oncology PA, at 1501 W Royal Ln, Irving, TX 75063 in Dallas County. The practice phone is (972) 997-8000.

Dr. Sturgeon's primary practice is Texas Oncology PA in Irving, Texas. The medical group on file is Texas Oncology. Dmand AI also links Dr. Sturgeon to 1 more group practice or clinic, named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Sturgeon practices. Vendor and product names are available with a free account.

Radiation oncology is Dr. Sturgeon's primary specialty in the NPI Registry, under taxonomy code 2085R0001X. Dr. Sturgeon is board certified in radiation oncology by the American Board of Radiology. Dmand AI has Dr. Sturgeon's licenses on file in 3 states: Texas, Michigan and North Dakota.

Dmand AI lists anal cancer radiation, bone cancer radiation, breast cancer radiation, cancer radiation-upper GI, colorectal cancer radiation, head & neck cancer radiation, lung cancer radiation and lymphoma radiation among the conditions Dr. Sturgeon treats.

CMS data shows 17,610 Medicare services from Dr. Sturgeon across 31 procedure codes in 2024, for 405 Medicare patients. Medicare paid $2,185,434 for them. Every service was in an office.

CMS counts 405 Medicare patients who saw Dr. Sturgeon in 2024. The largest group is 65 to 74, with 225 patients. 75% of them have high blood pressure, and 75% have high cholesterol. Their average risk score is 1.95, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Sturgeon's median patient age at 68, with 46% women.

In 2024, Dr. Sturgeon wrote 206 Medicare Part D claims for 93 patients. 87% of them were for generic drugs. CMS names the drug for 151 of them, across 6 drugs with 11 or more claims each, at $3,329 in total drug cost. In 2023, CMS named 127 claims across 5 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 85 out of 100 for Dr. Sturgeon for performance year 2024, reported through an alternative payment model (APM). Dr. Sturgeon accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Sturgeon as offering telehealth.

Dmand AI links 10 papers to Dr. Sturgeon, published from 2003 to 2021. 2017 was the busiest year, with 2. The most frequent topics are Stroke, Age Distribution and Cerebral Hemorrhage. Dr. Sturgeon has published most often in Stroke. Dr. Sturgeon's most frequent co-authors are Musaddiq Javvad Awan, MD, Christie Mitchell Ballantyne, MD and George J. Chang, MD.

CMS Open Payments shows 23 general payments to Dr. Sturgeon from 9 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 100% of the total. Ion Beam Applications S.A. paid the most, $397.

Dr. Sturgeon graduated from University Of Minnesota Medical School in 2008.

Dr. Sturgeon is in network with 23 carriers, including Elevance, Aetna and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 14. Check the plan with the practice before a visit.